Interestingly, when we were writing our finding that the association between NOTCH4 mutation and ICI response was established, we found a study in which NOTCH4 predicted immune efficacy in pan-cancer, including NSCLC and melanoma (20). This evidence concerns the gene NOTCH4 and melanoma.